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Several adoptive transfer systems for the detection of thymocyte progenitors 
have  been  developed in  rats  and  mice  (1-6).  Although  these  assays  vary  in 
methodological detail, all use an i.v. route of cell transfer to study the ability of 
hemopoietic precursors to repopulate the thymus of irradiated recipients. These 
transfer systems have permitted significant progress in the identification, isola- 
tion,  and  characterization  of prothymocytes and  in  the  general  analysis  of 
thymocytopoiesis (e.g.,  7-10).  However, the i.v.  transfer systems have several 
properties that limit their usefulness for detailed studies of thymocyte develop- 
ment. Among these limiting factors are low sensitivity, the requirement for cell 
migration, and the engraftment of pluripotent hemopoietic stem cells and lymph- 
oid stem cells in extrathymic sites. Consequently, in the i.v.  systems, relatively 
large numbers of precursor cells are required to generate detectable numbers of 
donor-origin thymocytes; only those subsets of precursor cells that are able to 
migrate from blood to thymus are detected; and the fine analysis of thymocyto- 
poiesis is obscured by the continual seeding of donor-origin prothymocytes from 
the chimeric bone marrow to the thymus of the adoptive host. These factors are 
especially troublesome in the study of intrathymic precursor cells. 
Herein, we describe a  quantitative, intrathymic (i.t.) ~ adoptive transfer assay 
system that detects the generation of donor-origin thymocytes after the injection 
of thymocyte precursors directly into the thymus of sublethally irradiated rats 
and mice. The i.t. transfer assay, being independent of cell migration, is much 
more sensitive than is the i.v. transfer assay, and can detect subsets of nonmigra- 
tory as well as migratory thymocyte precursors.  Furthermore, the i.t.  transfer 
assay is entirely selective for T-lineage precursor cells, and readily detects both 
intrathymic and  prethymic populations  of precursor cells;  yet neither  hemo- 
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poietic  nor  lymphopoietic stem cell  chimerism  occurs at  extrathymic sites.  Be- 
cause  of these  unique  properties,  we  anticipate  that  the  i.t.  adoptive  transfer 
system will greatly facilitate the identification  and isolation of subsets of thymo- 
cyte precursors and the  detailed  analysis of thymocyte development and differ- 
entiation. 
Materials and  Methods 
Animals.  Rats of the BUF (RT-1 b, RT-7  b, IgK-l"), M520 (RT-I b, RT-7  ", IgK-l"), LEW 
(RT-I I,  RT-7",bIgK-I"  ),  and  NBR  (RT-1 ~,  RT-7  b,  IgK-1  a)  inbred  strains  and  mice  of 
C57BL/6  (H-2,  Ly-l.2)  inbred  strain  were  obtained  from  the  Animal  Genetics  and 
Production Branch, Division of Cancer Treatment, National Cancer Institute, Frederick, 
MD.  Breeding  pairs of the  ALB  (RT-1 b,  RT-7  b,  IgK-1  b)  inbred  rat  strain  and  of the 
C57BL/6-Ly-1.1 (H-2  b, Ly-1.1) inbred mouse strain were obtained from the Small Animal 
Section, Division of Research Services, National Institutes of Health and from Dr. Edward 
Boyse, Memorial Sloan-Kettering Cancer Center, New York, respectively. Rats and mice 
used in  these experiments were 5-7  wk old and were maintained on commercial chow 
and acidified, chlorinated water (pH 2.2; free chlorine, 5-10 ppm) ad libitum. 
Antisera.  Hybridoma cell  lines  secreting  mAb against  the  RT-7.1  (BC84) and  the 
presumptive RT-7.2 (8G6.1) rat pan-T cell alloantigens (1 l,  12) are maintained in our 
laboratory. The 8G6.1 hybridoma cell line was developed by and was the kind gift of Dr. 
D. M.  Lubaroff, University of Iowa, Iowa City, IA. mAb against the IgK-1  a (MAR 80.2) 
and IgK-1  b (RG  11/15.1)  kappa chain alloantigens,  which are present on 95%  of rat B 
cells (13-15), were a kind gift of Dr. G. A. Gutman (University of California, Irvine, CA). 
The mouse mAb OX8 and W3/25, which react with discrete T cell subsets in the rat (16), 
were obtained from Accurate Chemical & Scientific Corp., Westbury, NY. mAb against 
the Ly-1.1 and Ly-l.2 mouse pan-T cell alloantigens were obtained from New England 
Nuclear, Boston, MA. The hybridoma secreting the rat mAb against a common determi- 
nant of mouse Ly-2 (53-6.72) was obtained from the American Type Culture Collection 
(17). An affinity-purified IgG fraction of rabbit anti-terminal deoxynucleotidyl transferase 
(anti°TdT) (18, 19) was a generous gift of Dr. F.J. Bollum, Uniformed Services University 
of the Health Sciences, Bethesda, MD. 
Cell Suspension Preparation.  Bone marrow cells were prepared by flushing the marrow 
from the tibia and femur with cold media (RPMI  1640).  Repeated gentle pipetting with 
a  flame-polished pipette  further  dispersed  the  cells,  which  were  then  washed  in  cold 
medium.  Thymus,  spleen, and  cervical lymph node cell  suspensions were prepared by 
gently pressing the tissues through  a  stainless steel  screen  followed by washing in  cold 
medium.  Peripheral  blood cells  obtained from vessels in  the tail (rat) or axilla (mouse) 
were collected  in  Alsevers solution.  Spleen  cell suspensions and  peripheral  blood cells 
were depleted of erythrocytes by hypotonic treatment with 0.168 M NH4C1. Cell viability 
was determined by exclusion of 0.1% trypan blue. 
lmmunofluorescence.  Rat thymus cells were labeled in suspension with RT-7.1  or RT° 
7.2 antibodies and developed for indirect immunofluorescence with a fluorescein-conju- 
gated F(ab')2 fragment of a goat anti-rat IgG (H and L chain-specific) (Cappel Labora- 
tories, Cochranville, PA) (1).  Double immunofluorescence for surface RT-7 and intranu- 
clear TdT was performed by preparing fixed smears of the RT-7-stained cells, developed 
with a rhodamine-conjugated F(ab').~ fragment of goat anti-rat IgG (heavy and light chain 
specific), and by labeling with anti-TdT and fluorescein-conjugated goat anti-rabbit lgG 
(Cappel Laboratories) (20). 
Mouse  thymus cells  were  labeled  in  suspension  with  Ly-l.1  or  Ly-l.2 antisera  and 
developed for indirect immunofluorescence witb fluorescein-conjugated F(ab')2 goat anti- 
mouse IgG (H and L chain-specific) (Cappel Laboratories). Double immunofluorescence 
for Ly-  1.1 (donor-origin thymocytes) and TdT was performed as above using a rhodamine- 
conjugated F(ab')2 fragment of goat anti-mouse lgG to develop the anti-Ly-1.1 antibodies 
and fluorescein-conj ugated goat anti-rabbit IgG to develop the anti-TdT antibodies (21). 
Donor- and host-origin rat, splenic, kappa chain-bearing B cells were quantified using GOLDSCHNEIDER El"  AI~.  3 
the  mAb  MAR  80.2  (anti-IgK-l")  and  RG  11/15.1  (anti-IgK-lb).  Labeled  cells  were 
developed  for  fluorescence  analysis  using  a  fluorescein-conjugated  F(ab')2  goat  anti- 
mouse IgG (H and L chain-specific) that had been passed over a normal rat Ig Sepharose 
4B affinity column to remove crossreacting antibodies (1). 
Double  immunofluorescence  for  the  rat  RT-7.1  and  OX8  or  W3/25  antigens  was 
performed  as  follows:  spleen  or  lymph  node  cells  were  first  labeled  with  fluorescein- 
conjugated anti-RT-7.1  to identify donor-origin cells.  Cells were then labeled with OX8 
or W3/25 mAb and developed for indirect immunofluorescence using rhodamine-conju- 
gated F(ab')2 goat anti-mouse IgG (H and L chain-specific) that had been passed over a 
normal rat IgG Sepharose 4B affinity column to remove crossreacting antibodies (1). 
Double immunofluorescence for the mouse Ly-l.1 and  Ly-2 antigens was performed 
as follows: spleen cells were first labeled with mouse anti-Ly-1.1 and developed for indirect 
immunofluorescence  with  fluorescein-conjugated  goat  anti-mouse  IgG  that  had  been 
passed  over  a  normal  rat  Ig  Sepharose  4B  affinity  column  to  remove  crossreacting 
antibodies.  Cells were then labeled with rat anti-Ly-2 and developed for indirect immu- 
no  fluorescence using rhodamine-conjugated F(ab')~ goat anti-rat IgG that had been passed 
over a normal mouse IgG Sepharose 4B affinity column to remove crossreacting antibodies 
(1). 
Cell suspensions were analyzed according to low angle light scatter and relative fluo- 
rescence intensity on a  FACS (FACS IV; Becton Dickinson Immunocytometry Systems, 
Sunnyvale,  CA)  equipped  with  a  dual-fluorescence  compensation  network  (I,  9).  Cell 
smears were analyzed visually using a  Zeiss Universal fluorescence microscope equipped 
with narrow band filters for rhodamine and fluorescein. 
Irradiation.  Recipients  received  total  body  irradiation  from  a  ~VCs source  (110 
tad/rain) (Gamma Ceil 40 Irradiator; Atomic Energy of Canada,  Ltd., Ottawa,  Canada) 
2-6 h before receiving bone marrow cells. 
In  Vivo CFU-S.  In  vivo spleen  CFU  (CFU-S)  activity  was  determined  by counting 
spleen colonies  12 d  (rats) or 9 d  (mice) after the intravenous or intrathymic transfer of 
bone marrow cells into irradiated (700-750 rad), histocompatible,  5-6-wk-old recipients 
(22, 23). 
Intrathymic Adoptive Transfer Assay  for Prothymocytes.  Rats and mice were anesthetized 
with a mixture of ketamine hydrochloride (1.20 rag/100 g body weight) (Ketaset; Bristol 
Laboratories  Div.,  Bristol-Myers  Co.,  Syracuse,  NY)  and  acepromazine  maleate  (0.12 
mg/100 g body weight) (PromAce; Fort Dodge Laboratories, Fort Dodge, IA), a muscle 
relaxant, injected i.p. A midline incision was made in the skin overlying the lower cervical 
and upper thoracic region, and the upper third of the sternum was bisected longitudinally 
with  fine scissors to expose the  thymus.  Suspensions  of bone  marrow,  thymus,  spleen, 
lymph node, or peripheral  blood cells were injected at two sites in the anterior superior 
portion of each thymus lobe (10/,l/site)  using a  1-ml syringe equipped with a  28-gauge 
needle  and  mounted on a  Tridak  Stepper  (Indicon  Inc.,  Brookfield Center,  CT).  The 
depth of the injection was not critical as long as the tip of the needle did not pass through 
the thymus and the injected material did not escape through the needle track. The incision 
was closed with wound clips.  When set up on an assembly line basis with two operators, 
-24 animals can be injected per hour. 
At various times after reconstitution, the recipients were killed and the percentages of 
donor- and host-origin cells were quantified by immunofluorescence analysis on the FACS. 
Donor-recipient strain combinations are reported in the text. Except when indicated, the 
results of individual experiments are presented.  However, all experiments were repeated 
two to six times, and comparable results were obtained. 
Intravenous Adoptive Transfer Assay  for Prothymocytes.  Details of this assay in rats and 
mice have  been  described  previously (1-6).  Briefly, irradiated  recipients  were injected 
intravenously via the tail vein with histocompatible, RT-7-disparate (rats) or Ly-1-disparate 
(mice)  donor  bone  marrow  cells.  Donor-recipient  strain  combinations  for  individual 
experiments  are  reported  in  the  text.  The  recipients  were  killed  and  percentages  of 
donor- and host-origin RT-7 + (rats) or Ly- 1  + (mice) thymocytes and T cells were quantified 
by immunofluorescence analysis on the FACS at various times after reconstitution. 4  INTRATHYMIC  TRANSFER  ASSAY  FOR  THYMOCYTE  PRECURSORS 
Results 
A  detailed description of the i.t.  adoptive transfer system in rats is presented 
below. Similar results were observed in mice so only a brief description of these 
experiments is provided, with complete data given in the figures and tables. 
Time Dependence of Thymocyte Regeneration.  The appearance  of donor-origin 
thymocytes  in  sublethally  irradiated  (600  tad)  recipients  as a  function of time 
was determined  after the i.t.  or i.v.  injection  of bone  marrow cells.  In the rat, 
significant  numbers of donor-origin  thymocytes  were  consistently  detected  by 
day  12 after the i.t.  transfer of 106 bone marrow cells, and by day  14 after the 
i.v.  transfer  of 2.5  ×  107  bone  marrow  cells  (Fig.  1A).  Thereafter,  a  parallel 
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FIGURE  I.  The kinetics of appearance of donor-origin thymocytes as a function of time after 
the transfer of bone marrow cells i.t. or i.v. (A) Irradiated (600 tad) BUF (RT-1 b, RT-7 b) rats 
received 104 M520 (RT-1 b, RT.7 a) bone marrow cells i.t. (solid line) or 2.5 ×  107 bone marrow 
cells i.v. (dashed line). The best fit line of two to four animals per group was determined by 
linear regression analysis (r  ~ =  0.99 and  1.00,  respectively). The slopes of the two lines (i.t. 
slope =  14.29, i.v. slope =  14.83) were not significantly different as determined by analysis of 
covariance (F -- 0.0083; degrees of freedom 1,39; p >  0.05). (B) Irradiated (600 rad) C57BL/6 
(H-2  b, Ly-1.2) mice received 10  s C57BL/6-Ly-1.1  (H-2 b, Ly-1.1) bone marrow cells i.t. (solid 
line) or 2.5  X  106  bone marrow cells i.v.  (dashed  line). The best fit curve of two to three 
animals per group was determined by exponential analysis (coefficient of determination r 2 = 
0.99 and 0.95, respectively). GOLDSCHNEIDER ET  AL. 
linear increase in the absolute number of donor-origin thymocytes occurred until 
days 20 or 22, respectively. ~8 x  106 donor-origin thymocytes were present on 
day 12 and  1.25 x  108 on day 20 in i.t.-injected recipients, representing  1.6 and 
19.9%,  respectively, of total  thymocytes.  However, between days 20  and  41, 
donor-origin  thymocytes  in  i.t.-injected  recipients  decreased  to  undetectable 
levels (<1%; <5 X  106), where they remained for at least 3 mo. In contrast, the 
i.v. injection of bone marrow cells resulted in the establishment of a permanent 
chimera. 
In  the  mouse, significant  numbers  of donor-origin  thymocytes appeared  on 
day 14 after the i.t. transfer of 105 and the i.v. transfer of 2.5 x  106 bone marrow 
cells. From day 14 through day 26 an exponential and superimposable increase 
in the number of donor-origin  thymocytes occurred in both assay systems (Fig. 
1 B).  This  was  followed  in  the  i.t.  system  by  a  decrease  in  the  donor-origin 
thymocyte number from 6.37 X  10  v on day 26 to 5.7 x  106 on day 35; whereas, 
in  the  i.v.  system,  donor-origin  thymocytes reached  a  plateau  by day  26  and 
formed a permanent chimera. 
In  both the  rat  and  mouse systems, examination  of cell suspensions  showed 
that  ~70%  of the  donor-origin  thymocytes were TdT + after  either  i.t.  or i.v. 
injection of bone marrow cells, which approximates normal values (18). 
Dose Dependence of Thymocyte Regeneration.  In  the  rat,  there  was  a  direct 
relationship  between  the  number  of bone  marrow  cells  injected  i.t.  and  the 
absolute number  of donor-origin  thymocytes observed in  irradiated  recipients 
between day  14 and day 20, i.e.,  during  the linear phase of the time response 
(see Fig.  1 A). Fig. 2A shows the results for day 14. The dose response was linear 
in the range of 0.1  ×  106-1.5  ×  106 bone marrow cells. No further increase in 
the number of donor-origin  thymocytes was observed at higher  doses of bone 
marrow cells. 
Since the slopes of the time-response curves after the i.t.  and i.v. transfer of 
bone marrow cells are parallel in the rat (Fig.  1 A), the relative sensitivities of the 
two assays can be compared directly. Thus, in a representative experiment shown 
in Fig. 2A, as few as 5 ×  I0  ~ bone marrow cells injected i.t. were able to generate 
the same number of donor-origin thymocytes (1.9 X 107) by day 14, as were 2.5 
×  107 bone marrow cells injected i.v. The results of several similar experiments 
showed that the i.t. assay is ~40-fold more sensitive (range,  26-55-fold) than is 
the  i.v. assay in  detecting hemopoietic thymocyte progenitors  in the rat  when 
compared on the same day (Table I). When the relative sensitivity was calculated 
allowing for the 2 d-greater lag for the appearance of donor-origin thymocytes 
in the i.v. assay (Fig. 1 A), the i.t. assay was ~ 18-fold more sensitive (range,  12.5- 
27.8) than was the i.v. assay. 
In the mouse, the dose response of the i.t. assay was ~10-fold lower than that 
in the rat, being linear in the range of 0.75 ×  105-2.50 ×  105 bone marrow cells 
on day 17 (Fig. 2B). In addition,  the i.t. assay is ~25-fold more sensitive than is 
the i.v. assay when tested on day 17 (Table I). 
Irradiation Dependence of Thymocyte Regeneration.  The results in Table II show 
that  the  threshold  dose of irradiation  for the  generation  of donor-origin  thy- 
mocytes is ~400 rad in the mouse and  500 rad in the rat for both the i.t.  and 
i.v. assays. Doses of >_700 rad resulted in the sickness or death of the i.t.- but not 6  INTRATHYMIC  TRANSFER  ASSAY  FOR  THYMOCYTE  PRECURSORS 
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FIGURE  2.  The  kinetics of appearance  of donor-origin  thymocytes  as a  function of dose of 
bone  marrow  cells  injected  i.t.  into  irradiated  recipients.  (A)  Irradiated  (600  rad)  BUF  rats 
were  injected  i.t.  with  M520  bone  marrow  cells.  The  dose-response  relationship  was  linear 
(linear regression coefficient  r = =  0.97;  slope  --- 31.88)  in the dose  range of 0.1  ×  106-1.5  × 
106 bone marrow cells when examined during the linear phase of the time response (day  14). 
Recipients injected with 2.5  x  107 or 5.0  X  107 bone marrow  cells i.v. yielded  1.9  x  107 and 
4.0 x  107 donor-origin  thymocytes,  respectively,  demonstrating  that, at these doses and time 
point,  the  i.t.  transfer  system  is 41-49-fold  more  sensitive  than  is the i.v.  adoptive  transfer 
system (see Table  I). (B) Irradiated (600 tad) C57BL/6  mice were injected i.t. with C57BL/6- 
Ly-l.1  bone  marrow  cells.  The  dose-response  relationship  was  linear  (r ~  =  0.95;  slope  = 
135.98) in the dose range of 0.75  x  105-2.5  ×  102 bone marrow cells (closed circles, day  17; 
open circles, day  14).  Recipients injected  with 2.5  x  106 bone marrow  cells i.v. yielded 6.8  X 
106 donor-origin  thymocytes,  demonstrating  that, at this dose and time point the i.t.  transfer 
system is -25-fold  more sensitive than is the i.v. transfer system (see Table I). 
the i.v.-injected animals.  Therefore, as indicated below, when irradiation doses 
>600  rad  were  used,  limiting  numbers  of syngeneic host-origin  bone  marrow 
cells were given i.v. to rescue the i.t.-injected animals, since it appears that there 
is  no  significant  seeding  of donor-origin  bone  marrow  cells  to  the  recipient's 
bone marrow in the i.t. system. 
Generation  of Peripheral  T  Cells.  In  the  rat  system,  10 7  bone  marrow  cells 
were  transferred  either  i.t.  or  i.v.  into  lethally (750  rad)  irradiated  recipients. 
This  high  irradiation  dose  was  used  to  reduce  the  number  of surviving  host- GOLDSCHNEIDER  ET  AL. 
TABLE  I 
Relative Sensitivity of lntrathymic and Intravenous Assay Systems for 
Detecting Thymocyte Progenitors in Bone Marrow 
Days after bone  Ratio of intrathymic to 
Animal model  marrow cell  intravenous assays  transfer 
Rat  14  42 
14  31 
14  48 
14  50 
18  26 
19  55 
42.0 4- 11.4" 
Mouse  17  24 
Relative sensitivities of assays were determined by comparing the number of 
bone marrow cells required  to produce equivalent numbers of donor-origin 
thynlocytes on a  given day after injection i.t. or i.v. (see Fig. 2, A and B). To 
eliminate interexperimental variation, a  dose-response curve for the i,t. assay 
was constructed for each experiment, 
* Mean 4- SD. If one assumes a 48-h-increased lag period for the i,v, assay in the 
rat  (see Fig,  1A), the relative sensitivity of the i.t.  assay is  18.5  (4-5.4) times 
greater than that of the i.v. assay. 
TABLE  II 
Effect of Irradiation Dose on Generation of Donor-origin  Thymocytes in 
lntrathymic Adoptive Transfer System 
Dose of  Route of bone 
marrow cell  irradiation 
transfer 
Number of donor-origin thymocytes 
per thymus (Xl0 -6) 
Rat*  Mouse* 
rad 
0 
300 
400 
500 
600 
i.v.  <1  <1 
Lt.  <1  <1 
I.v.  <1  <1 
~.t.  <1  4.5 4- 3.7 
Lv.  <1  6,9 4- 8.8 
Lt.  <1  7.5 4- 3.9 
1.v.  8.3 4- 1.9  7,1  4- 9.4 
Lt.  47.6 4- 26.3  12.5 4- 8.4 
l.v.  17.6 4- 15.3  3.7 4- 1.1 
ut.  44.8 4- 14,7  28.6 4- 3.0 
*  BUF (RT-7 b) recipients were irradiated and injected within 2-6 h  with  10  × 
106 M520 (RT-7 a) bone marrow cells i,t. or i,v. Donor-origin thymocytes (RT- 
7.1) were quantified by immunofluorescence analysis on the FACS 16 d  later. 
Results represent the mean  4- SD of three animals per group.  Values of <1 
indicate that no donor-origin thymocytes were detected. 
* C57BL/6  recipients (Ly-l.2) were irradiated and  injected within 2-6  h  with 
C57BL/6-Ly-l.1  bone marrow cells i.t. (0,1  X  106) or i.v. (2.5 x  106).  Donor- 
origin thymocytes (Ly-1.1) were quantified by immunofluorescence analysis on 
the FACS  17 d  later. 8  INTRATHYMIC TRANSFER  ASSAY  FOR  THYMOCYTE  PRECURSORS 
origin  T  cells,  thereby  facilitating  the  detection  of donor-origin  T  cells.  Each 
recipient  also  received  a  hemopoietic  rescue  dose  of 5  X  106  syngeneic  bone 
marrow cells. 
By day  30,  significant  numbers  of donor-origin  T  cells  were  detected  in  the 
spleen  of both  the  i.t.-  and  i.v.-injected  recipients  (Table  III).  Donor-origin  T 
cells  were also detected  in  the  lymph nodes  of these animals  (data  not shown). 
The antigenic phenotypes of the donor-origin T  cells were determined by double 
immunofluorescence  using  mAb  W3/25  and  OX8  as  selective  T  cell  subset 
markers,  and  mAb  against  RT-7.1  as  a  marker  for donor-origin  T  cells.  The 
ratio  of presumptive  helper/inducer  (W3/25 ÷)  to cytotoxic/suppressor  (OX8 +) 
donor-origin T  cell  subsets  were comparable  in the  i.t.- and  i.v.-injected  recipi- 
ents,  and  approximated  the  expected  ratio  of  1:1  in  normal  nonirradiated 
controls (Table  III). Comparable  results  were observed in the mouse system,  in 
which  the  i.t.  transfer  of 105  bone  marrow  cells  resulted  in  the  generation  of 
detectable  numbers of donor-origin T  cells by about day 30 (Table  III). 
Absence of Donor Origin Hemopoietic Spleen  Colonies or B Cell Regeneration  in i.t.- 
injected Recipients.  No donor-origin hemopoietic colonies were observed in the 
spleens  of irradiated  (750  tad)  recipients  that were injected  i.t.  with  10  ~ or  107 
rat bone marrow cells or 0,-75 x  103-2.50 x  105 mouse bone marrow cells (Table 
IV). In contrast,  the spleens of rats and mice injected i.v.  with  106 and  105 bone 
marrow cells, respectively, contained the expected numbers of colonies. 
Similarly,  as determined  by mAb against  rat  kappa chain  Ig allotypes (2,  13- 
TABLE  III 
Generation of Donor-origin T Lymphocytes in lntrathymic Adoptive Transfer System 
Number 
of cells  Percentage of  Number of 
Animal  Route of bone marrow  donor-origin  donor-origin 
model  cell transfer*  trans-  ferred  T ceils per  T cells per 
(X 10 -6)  spleen  spleen (× 10  -6) 
Ratio of 
donor-ori- 
gin T 
helper to 
T sup- 
pressor 
cells in 
spleen ~ 
Rat  i.v,  l0  9.5 _+ 0.9  13.8 4- 8.1  1:1 
i.t.  10  8.5 _+ 0.6  7.6 4- 2.3  0.7:1 
Uninjected  controls  --  --  --  0,9:1 
Mouse  i.v.  2.5  7.0  2.8  2.4:1 
i.t.  0.1  3.1  0.9  1:1 
Uninjected  controls  --  --  --  2:1 
* Irradiated (750 rad) BUF (RT-7  b) rats were injected  i.t. or i.v. with M520 (RT-7  a) bone marrow 
cells. Both groups also received a hemopoietic rescue dose of 5 x  106 syngeneic (BUF) bone marrow 
cells i.v. Donor-origin  T  cells (RT-7.1)  in  the spleen  were quantified  by immunofluorescence 
analysis on the FACS 30 d after reconstitution.  Irradiated (700 rad) C57BL/6 (Ly-l.2) mice were 
injected i.t, or i.v. with C57BL/6-Ly 1.1 bone marrow cells. Both groups also received a hemopoietic 
rescue dose of 0.5 X 108 syngeneic C57BL/6 (Ly-l.2) bone marrow cells i.v. Donor-origin T ceils 
(Ly-  I. 1) in the spleen were quantified  29 d after reconstitution.  Control animals were age- and sex- 
matched,  unirradiated M520 rats and C57BL/6-Ly 1.1 mice, respectively. 
* Determined  by  double  immunofluorescence,  for  RT-7.1  (donor-origin)  and  W3/25 
(helper/inducer) or OX8 (suppressor/cytotoxic)  T cell subsets in the rat,  and for Ly-l.1 (donor- 
origin T  cells) and Ly-2- (helper/inducer) and Ly-2  + (suppressor/cytotoxic)  T  cell subsets in the 
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TABLE  IV 
Absence of Donor-origin Hemopoietic Spleen Colonies and B Lymphocyte Regeneration in 
Intrathymic Adoptive Transfer System 
Days  Route of  Number of  Number of  after  Number of do-  Number of 
Animal  bone  bone  bone mar-  nor-origin thy-  hemopoietic  donor-origin B 
marrow  row cells  mocytes per thy-  spleen  lymphocytes 
model  marrow  cell  transferred  per spleen 
cell  m us (× 10  -6)  colonies 
transfer  transfer  (× 10  -8)  (× 10  -6  ) 
Rat  12  i.v.  1  <l  23.5 ±  3.5  <1 
i.t.  1  12.9 ±  6.5  <1  <l 
i.t.  10  53.7 ±  12.5  <1  <1 
15  i.v.  1  <1  23.2 
i.v.  25  42.0 ±  0.7  70.8 +  15.9 
i.t.  1  37.0 ±  11.6  <1 
i.t.  10  30.6 ±  7.8  <1 
31  i.v.  25  289.0 +_. 130.9  101.4 +_ 
i.t.  1  29.2 +  35.2  <1 
i.t.  10  17.2 +  19.8  <1 
13.5 
72  i.v.  50  543.6 _+ 144.8  80.0 +  7.5 
i.t.  10  <1  <1 
Mouse  9  i.v.  0.100  15.0 _  0.0  ND 
i.t.  0.250  <1  ND 
i.t.  0.100  <1  ND 
i.t.  0.075  <1  ND 
Irradiated (600-750 rad) M520 (RT-7  a, IgK-I  ~) rats were injected i.t. or i.v. with varying numbers 
of histocompatible ALB (RT-7  b, lgK-1 b) bone marrow cells.  Donor-origin thymocytes (RT-7.2) and 
splenic B lymphocytes (tgK-1  b) were quantified by immunofluorescence analysis on the  FACS at 
various days after reconstitution. Results represent the mean +  SD of three animals per group. 
Values of<l indicate that no donor-origin hemopoietic spleen colonies, thymocytes, or B lymphocytes 
were detected.  ND, not determined. Hemopoietic spleen colony values were corrected for colonies 
produced from endogenous stem cells. Irradiated (700 rad) C57BL/6 (Ly 1.2) mice were injected i.t. 
or i.v. with varying numbers of C57BL/6-Ly 1. I bone marrow cells. Spleens were removed on day 9 
after cell transfer and fixed, and hemopoietic spleen colonies were enumerated. 
15), no donor-origin  B  cells were observed  in the spleens of irradiated  recipients 
15  d  after  i.t.  injection  of  106  or  105  rat  bone  marrow  cells.  However,  >60% 
(2.32  ×  107) of the splenic B  cells in recipients of 106 bone  marrow  cells injected 
i.v. were  of donor  origin by day  15.  Even by days 31  and  72,  no donor-origin  B 
lymphocytes  were  detected  in  the  spleens  of  i.t.-injected  recipients,  whereas 
permanent  B  cell chimeras  were established in the i.v.-injected recipients. 
Absence  of Donor-origin  Prothymocyte  Activity  in  Bone  Marrow  of  i.t.-injected 
Recipients.  107  rat  bone  marrow  cells  from  rats  that  had  received  106  bone 
marrow  cells  i.t.  or  2.5  ×  107  bone  marrow  cells  i.v.  15  d  previously  were 
transferred  by i.t. injection into secondary  recipients (Table V). No donor-origin 
thymocytes  were  observed  in the secondary  recipients given bone  marrow  from 
the  i.t.-injected  donors,  whereas  6.98  ×  107  donor-origin  thymocytes  were 
detected  in  the  secondary  recipients given  bone  marrow  from  the  i.v.-injected 
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TABLE V 
Absence of Donor-origin Prothymocyte Activity in Bone Marrow of 
Intrathymically Injected Recipients 
Primary bone  Secondary bone 
marrow cell  marrow cell  Number of donor- 
Animal  transfer  transfer  origin thymocytes per 
thymus in secondary 
model  Number of  Number  recipients on day  16 
Route  cells  Route  of cells  (x 10 -6) 
(x 10  -6)  (x 10  -6) 
Rat  i.v.  25  i.t.  10  69.8 _  47.4 
i.t.  1  i.t.  10  <1 
Mouse  i.v.  2.5  i.t.  5  10.6 _  4.8 
i.t.  0.1  i.t.  5  <1 
h'radiated (600 rad) M520 (RT-7 a) rats were injected i.t. or i.v. with ALB (RT- 
7 b) bone  marrow  cells.  15  d  after  reconstitution,  bone  marrow  cells from  the 
primary  recipients  were  transferred  by  i.t.  injection  into  irradiated  (600  tad) 
M520 secondary  recipients.  16 d  later,  donor-origin  thymocytes (RT-7.2)  were 
quantified  in  the  secondary  recipients  by immunofluorescence  analysis on  the 
FACS.  Results represent the mean +  SD of three animals per group.  Values of 
<1  indicate that no donor-origin thymocytes were detected.  Irradiated (600 rad) 
C57BI./6  (Ly-l.2)  mice  were  injected  i.t.  or  i.v.  with  C57BL/6-Ly  1.1  bone 
marrow cells. 35 d after transfer, bone marrow cells from the primary recipients 
were  transferred  by  i.t.  injection  into  irradiated  (600  rad)  C57BL/6-Ly  1.2 
secondary recipients.  16 d  later, donor-origin  thymocytes (Ly-1.1)  were quanti- 
fied in the secondary recipients. 
Tissue Distribution  of Cells Capable of Generating Thymocytes in i.t.-injected  Recip- 
ients.  The  results  in  Table  VI  indicate  that,  of several  hemopoietic  tissues 
examined in both the rat and mouse, bone marrow has the greatest thymocyte- 
regenerative capacity, on a per-cell basis, and lymph node has the least (if any). 
Spleen and  peripheral  blood are intermediate  in  their  capacities to regenerate 
thymocytes in irradiated  recipients. 
It is notable that  the i.t.  injection of 107  rat  thymus cells yielded 2.53  x  107 
donor-origin thymocytes by day 14 after transfer, indicating that the i.t.  transfer 
assay readily detects intrathymic as well as prethymic precursor cells. Moreover, 
results in  Fig.  3 show that there is a direct relationship  between the number of 
thymocytes injected  i.t.  and  the  number  of donor-origin  thymocytes detected. 
The dose-response relationship was linear in the range of 2.5 x  106-|0.0  X  106 
thymocytes transferred.  Results in  Fig.  3 also indicate  that,  when  measured at 
day 14, the i.t. transfer assay is ~53 times more sensitive than is the i.v.  transfer 
system in detecting intrathymic precursor cell activity. 
Discussion 
Our results show that  the i.t.  transfer  system for thymocyte precursors,  like 
the traditional  i.v.  transfer system, is quantitative  with regard to time and dose 
and is irradiation  dependent. Indeed, when adjusted for the dose of transferred 
cells, the kinetics of thymocyte and peripheral  T  cell generation  in both assays 
are roughly comparable, as are the ratios of TdT + and TdT- thymocyte subsets 
and  T  cell subsets with  helper and suppressor antigenic  phenotypes.  However, GOLDSCHNEIDER  ET  AL. 
TABLE  V1 
Tissue Distribution of Thymocyte Progenitor Activity as Detected by 
Intrathymic Adoptive  Transfer System 
11 
Number  Number of do-  of cells 
Animal  Origin of cells  trans-  nor-origin thy- 
model  transferred  ferred  mocytes per thy- 
(Xl0_~)  mus (xl0  -~) 
Rat 
Mouse 
Bone marrow  1  18.1  --- 5.9 
Thymus  10  25.3 +- 6.9 
Spleen  5  13.6 +  7.9 
Lymph node  10  <1 
Peripheral blood  5  14.9 --- 12.9 
Bone marrow  0.1  2.5 
Thymus  2.0  3.2 
Spleen  0.5  4.3 
Lymph node  5.0  <1 
Peripheral blood  1.0  10.2 
Irradiated (600  tad)  LEW  (RT-7  ~) rats were  injected i.t.  with histocom- 
patible NBR (RT-7 b) cells obtained from various lymphoid tissues. Donor- 
origin thymocytes (RT-7.2) were quantified 14 days after cell transfer by 
indirect immunofluorescence analysis on the FACS. Results represent the 
mean _+ SD of three animals per group. Values <1 indicate that no donor- 
origin thymocytes were detected.  Irradiated (600 tad) C57BL/6 (Ly-l.2) 
mice were injected i.t. with C57BL/6-Ly  1.1  cells obtained from various 
lymphoid tissues.  Donor-origin thymocytes (Ly-I. 1) were quantified  15 d 
after cell transfer. 
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FIGURE  3.  The kinetics of appearance of donor-origin thymocytes on day  14 as a  function 
of the dose of NBR  (RT-I I,  RT-7  b) thymocytes injected i.t.  into irradiated (600  rad)  LEW 
(RT-I i, RT_7  ~) rats. The dose-response relationship was linear (linear regression coefficient r ~ 
=  0.99;  slope  =  2.93)  in  the dose  range  of 2.5  x  106-10.0  x  106  thymocytes.  Recipients 
injected with  l08 thymocytes i.v. yielded 9,0  x  106 donor-origin thymocytes, demonstrating 
that, at this dose and time point, the i.t.  transfer system is 53-fold more sensitive than is the 
i.v. transfer system at detecting intrathymic precursor cells. 12  INTRATHYMIC  TRANSFER  ASSAY  FOR  THYMOCYTE  PRECURSORS 
there are three major differences between the i.t.  and i.v.  assay systems that 
enable them to address different aspects of thymocytopoiesis. (a) The i.t. assay 
system  is  significantly  more  sensitive  than  is  the  i.v.  assay  system,  thereby 
enhancing the ability to detect both prethymic and intrathymic precursor cells. 
(b) The i.t. assay system is not dependent upon the ability ofthymocyte  precursors 
to migrate to the thymus. This presumably accounts in large part for the increased 
sensitivity of the i.t. assay, and theoretically should enable precursor cells that 
have not  yet acquired  migratory properties  and/or  that  have  lost  migratory 
properties  to  be  detected.  (c)  The  i.t.  transfer  system  does  not  permit  the 
extrathymic engraftment of donor-origin  hemopoietic spleen colonies, B  lym- 
phocyte progenitors, or prothymocytes in irradiated recipients. This permits the 
generation of donor-origin thymocytes and T  cells to be studied in the absence 
of continuous seeding of lymphoid precursor cells from the bone marrow. These 
unique properties of the i.t.  transfer system and some implications regarding 
thymocytopoiesis are discussed briefly below. 
Other things being equal, comparison of the relative sensitivities of the i.t. and 
i.v.  transfer systems during  the  linear phase  of the  time and  dose  responses 
should  permit  a  rough  estimate  of the  seeding  efficiency of bone  marrow 
prothymocytes to the thymus after i.v.  injection. Thus, assuming that all of the 
prothymocytes that are injected i.t.  survive and proliferate, and assuming that 
both assays detect the same population(s) of prothymocytes, it can be calculated 
that  the  seeding  efficiency of mouse prothymocytes in  the  i.v.  assay  is  0.04 
(1/24).  In the rat,  this value would be between 0.02  and 0.06,  depending on 
whether or not the relative sensitivity of the i.v.  transfer system (1/42 to  1/18) 
is corrected for the 48-h difference in the appearance of donor-origin cells (see 
Fig.  1A). 
It is possible that the estimated seeding efficiency for prothymocytes in the i.v. 
assay is too high, because the i.t. transfer system may not be  100% efficient, or 
too low, because the i.t.  transfer system may detect populations  of prethymic 
cells that are unable to home to the thymus. Regarding the latter possibility, we 
have used the FACS to separate two subsets of rat prothymocytes, both of which 
generate thymocytes in the i.t. assay, but only one of which does so in the i.v. 
assay (9, 24, and unpublished observations). In addition, we have observed that 
prethymic cells in the bone marrow of motheaten (me/me) mice, which undergo 
premature  thymic  involution  (25),  can  repopulate  the  thymus  of irradiated 
normal recipients after i.t.  but not i.v. injection.  2 
Similar phenomena may also apply to  intrathymic precursor cells,  some of 
which are able to proliferate in the i.t. assay but apparently are not able to home 
to the thymus in  the i.v.  assay (B.  Mathieson,  personal communication). This 
may account in part for the high efficiency of the i.t. transfer system in detecting 
intrathymic precursor cells. 
Numerous reports using the i.v. assay (e.g.,  1, 2,  26) have indicated that the 
relative frequency of thymocyte progenitors in hemopoietic tissues, in order of 
decreasing frequency, are bone marrow >  spleen >  thymus >  lymph node. We 
have obtained similar results using the i.t. assay system. In each instance, however, 
Greiner, D. L., K. L. Komschlies, I. Goldschneider, and L. Schultz. Prothymocyte development 
in the motheaten (me/me) mutant mouse. Manuscript in preparation. GOLDSCHNEIDER ET  AL.  13 
25-50-fold  fewer cells were required in  the i.t.  assay than  in  the i.v.  assay to 
generate equivalent numbers of donor-origin thymocytes in the adoptive recipi- 
ents.  It is important that, even given the increased sensitivity of the i.t.  assay, 
lymph node cells were unable to generate donor-origin thymocytes. Hence, it is 
highly probable that the donor-origin thymocytes  detected in the i.t. assay system, 
including these produced by intrathymic cells, arise from developmentally im- 
mature cells and not from the resident pool of immunologically competent cells. 
In this regard, Fowlkes et al. (10) have used the i.v. transfer system to identify a 
population of presumptive intrathymic precursor cells that appears to be able to 
repopulate  all  of the  cellular  compartments of the  thymus  in  mice.  This  is 
consistent with our observation that the i.t.  injection of intrathymic (as well as 
prethymic) precursors results in the generation of TdT  ÷ and TdT- donor-origin 
thymocytes, thereby suggesting that  both  cortical and  medullary tbymocytes, 
respectively, are generated in this system as well (19). 
As  noted,  the  i.t.  assay  in  the  rat  and  mouse  results  in  the  selective  and 
temporary engraftment of thymocyte precursors intrathymically only. No donor- 
origin hemopoietic colonies or B lymphocytes were detected in the spleen, and 
no  donor-origin  prothymocyte activity  was  detected in  the  bone  marrow  of 
adoptive recipients after the i.t.  injection of 10 times more bone marrow cells 
than was necessary for optimal thymocyte  regeneration. In the i.v. assay, however, 
donor-origin CFU-S, B cell progenitors, and prothymocytes seeded extrathymi- 
cally, resulting in  the establishment of permanent hemopoietic and  B  and  T 
lymphocyte chimeras. 
It can be calculated from these experiments that < 1% of the transferred CFU- 
S,  B cell progenitors, and prothymocytes could have become engrafted extra- 
tbymica]ly in the i.t. assay system. Therefore, it is evident that the generation of 
donor-origin  thymocytes in  the  adoptive  recipients  resulted  from  the  local 
proliferation of the intrathymically injected precursor cells. Moreover, the results 
suggest that thymocyte regeneration in the i.t. system is not due to pluripotent 
stem cells, since the i.t.-engrafted precursors apparently have a limited capacity 
for self-renewal. Hence, in contrast to the i.v. assay, where continuous generation 
and seeding of thymocyte progenitors to the thymus occurs, a self-limiting wave 
of donor-origin thymocytopoiesis occurs in the i.t. assay system. 
Exponential regression analysis of the time-response curve has commonly been 
used to  estimate the number of prothymocytes that  enter the thymus shortly 
after the i.v.  transfer of bone marrow cells into irradiated recipients (1,  3,  4). 
However, similar analysis of the kinetics of thymocyte generation in the i.t. assay, 
in which considerations of seeding efficiency and stem cell chimerism are not 
germane, show that this statistical approach is unreliable. Thus the y intercept 
calculated by  exponential  regression  analysis of the  data  in  Fig.  1,  A  and  B 
suggest that ~25% of the injected rat bone marrow cells and 50% of the injected 
mouse bone  marrow cells were prothymocytes, which is not credible (9).  The 
most  probable  explanation  for  this  overestimation  is  the  loss  of a  constant 
proportion of newly generated thymocytes by intrathymic death or migration to 
peripheral  lymphoid  tissues.  Thus,  the  calculated doubling  rates  in  the  time 
response curves of both the i.v. and i.t. assays are low (2.5 d in the mouse; 2.25 
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gross production of thymocytes. Only the latter data would permit the true y 
intercept to  be calculated, and  then  only if the doubling time were constant 
throughout the assay. 
One  of the  characteristic  features  of tbymocytopoiesis in  the  i.v.  transfer 
system is the  12-14-d  lag period that precedes the appearance of donor-origin 
thymocytes. Although the explanation  for this phenomenon is not known (re- 
viewed in  1), Kadish and Basch (3) have provided indirect evidence that the lag 
is not due to a  significant delay in the entry of the transferred prothymocytes 
into the thymus; migration apparently is completed within the first 48  h  after 
reconstitution.  Our  results  using the  i.t.  assay,  in  which the  requirement for 
migration is bypassed entirely, directly excludes this possible mechanism for the 
lag phase. Moreover, we have previously demonstrated (1) and confirm here that 
>98% of thymocytes in the RT-7-disparate rat chimeras and the Ly-l-disparate 
mouse chimeras can be positively identified as being of donor or host origin at 
all  stages  of regeneration,  thereby  excluding  the  possibility  that  significant 
numbers of donor-origin thymocytes escape detection because they fail to express 
detectable pan-T cell alloantigens during the lag period. 
An important feature of the dose-response curve in the i.t. transfer system is 
the occurrence of a plateau of thymocyte production at peak levels over at least 
a  fivefo/d range  of prothymocytes (see  Fig.  2,  A  and  B).  This  has  not  been 
described  in  the  i.v.  transfer  system,  presumably  because  sufficiently  large 
numbers of bone marrow cells have not yet been transferred experimentally (we 
estimate that at least 10 ~ cells would be required in the rat). Further analysis of 
the  dose-response curve in  Fig.  2A  shows  that  it  saturates  in  an  exponential 
manner and reaches a limiting asymptote of 6.2 X 107 thymocytes as determined 
by reciprocal and hyperbolic equations (best fit, r 2  ----- 0.97) (27). This suggests as 
one possibility that the thymus has a finite number of microenvironmental sites 
or niches that can support thymocytopoiesis. Moreover, the time-response kinet- 
ics  (see  Fig.  1,  A  and  B)  suggest  that,  once  these  niches  are  saturated  by 
prothymocytes, any excess prothymocytes that might have been injected i.t. are 
not stimulated to proliferate, and apparently are unavailable or unable to refill 
these sites at a later time; hence, the rapid decrease that occurs in the numbers 
of donor-origin thymocytes after day 20 in the rat and day 26 in the mouse (see 
Fig.  l, A and B). Conversely, in the i.v.  transfer system, the number of donor- 
origin  thymocytes does  not  decrease  with  time,  presumably  because  vacated 
microenvironmental niches are filled by newly formed donor-origin prothymo- 
cytes, which emigrate from the chimeric bone marrow of the host. 
In his classical  experiments on thymus grafting between age-disparate donors 
and hosts,  Metca/f (28) demonstrated that the thymus functions autonomously 
to  regulate the kinetics of thymocytopoiesis. The  i.t.  transfer system offers a 
unique opportunity to explore the thymus microenvironment for this and related 
phenomena (e.g.,  "gating," physiological involution, radiation sensitivity) (1,  3, 
27, 28) by separating the purely intrathymic influences on thymocytopoiesis from 
the prethymic influences (e.g., stem cell chimerism, precursor cell migration). 
The i.t. transfer system also promises to provide a heretofore unavailable in vivo, 
organ culture-like environment in which the developmental potential and dif- 
ferentiation pathways of selected prethymic and intrathymic precursor cell sub- GOLDSCHNEIDER ET  AL.  15 
sets and their progeny can be defined.  Intrathymic  adoptive transfer studies in 
our and other laboratories currently are addressing these fundamental questions. 
Summary 
We  describe  a  quantitative  intrathymic  (i.t.)  adoptive  transfer  system  for 
detecting thymocyte precursor cells in rats and mice. In this system, the genera- 
tion of donor-origin  thymocytes is analyzed on the FACS after the injection of 
test cells directly into the thymus of sublethally irradiated,  histocompatible, RT- 
7  (rat)  or  Ly-1  (mouse) alloantigen-disparate  recipients.  Like the  standard  i.v. 
adoptive transfer assays for prothymocytes, the i.t.  transfer  assay is time, dose, 
and irradiation  dependent. However, unlike the i.v. assays, the i.t. assay is highly 
sensitive,  independent  of cell  migration,  and  specific for  T-lineage  precursor 
cells.  Thus,  the  i.t.  system requires  between  25-  and  50-fold fewer precursor 
cells  than  do  the  i.v.  systems  to  generate  a  given  number  of donor-origin 
thymocytes; it detects nonmigratory  as well as  migratory  subsets of precursor 
cells; it detects prethymic and intrathymic precursor cells with equal facility; and 
it produces a discrete, self-limited wave of donor-origin thymocytes and periph- 
eral T  cells. Moreover, neither hemopoietic nor lymphopoietic stem cell chimer- 
ism occurs at extrathymic sites. 
Comparison  of the  kinetics  of thymocytopoiesis in  the  i.t.  and  i.v.  transfer 
systems suggest  that  the  seeding  efficiency of prothymocytes in  the  i.v.  assay 
approximates 0.04; the lag phase of the time-response curve is not due to a delay 
in  the  entry  of prothymocytes  into  the  thymus;  and  the  relative  amount  of 
thymocyte precursor activity in various lymphohemopoietic tissues is highest in 
bone  marrow,  lowest (or  absent)  in  lymph  node,  and  intermediate  in  spleen, 
blood, and thymus. Moreover, the occurrence of saturation kinetics in the dose- 
response curve of the i.t. system supports the hypothesis that a finite number of 
microenvironmental  niches for prothymocytes may exist in the thymus.  These 
initial  observations  will  require  confirmation  and  extension  in  future  studies. 
However, based on the present findings and related observations, we anticipate 
that the i.t. adoptive transfer system will contribute importantly to the definitive 
analysis of both normal and abnormal thymocytopoiesis. 
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